Vermillion to Present at Leerink Global Healthcare Conference
News Feb 04, 2014
Vermillion, Inc. has been invited to present at Leerink Partners' Global Healthcare Conference. The conference will be held at the Waldorf Astoria Hotel in New York City from February 12-13, 2014.
President and CEO of Vermillion, Thomas McLain, is scheduled to present on Thursday, February 13, 2014 at 3:05 p.m. Eastern time.
He will be joined by Eric Schoen, the company's vice president of finance and chief accounting officer, for one-on-one meetings to be held throughout the day.
Management will discuss the company's initiatives to drive market adoption of OVA1®, as well as plans to expand its patient base and launch a next-generation diagnostic test.
Enterome and Nestlé Health Sciences Launch New Diagnostics CompanyNews
Enterome and Nestlé Health Sciences join to create Microbiome Diagnostics Partners, a company that will enable the development and diagnostics for multiple diseases including inflammatory bowel diseases (IBD) and liver diseases.READ MORE
Material From Shellfish Boosts Sensitivity of Diagnostic TestsNews
By adding polydopamine at a key step, the sensitivity of diagnostic tests and bioassays can be increased by as many as 100 to 1,000 times.READ MORE